Latest Debiopharm Stories
LAUSANNE, Switzerland, May 6, 2014 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs
- Debio 0932 demonstrated anti-tumor activity and synergy with various SOC agents in in vitro and xenograft models of NSCLC and RCC - LAUSANNE, Switzerland and LEXINGTON, Mass., April
LAUSANNE, Switzerland and HAMBURG, Germany, April 2, 2014 /PRNewswire/ -- - Innovative partnership based on Evotec's Target X projects
LAUSANNE, Switzerland, March 6, 2014 /PRNewswire/ -- Debiopharm Group(TM)(Debiopharm), a Swiss-based global biopharmaceutical group of companies active in drug development,
LAUSANNE, Switzerland, February 28, 2014 /PRNewswire/ -- Unilabs, a leading supplier of clinical laboratory and medical diagnostic imaging services in Europe and Diagnoplex
LAUSANNE, Switzerland, January 8, 2014 /PRNewswire/ -- Spinomix SA, a Swiss company advancing molecular diagnostic through innovative sample preparation technologies and
- One of a pair of round metal cymbals attached to the fingers and struck together for rhythm and percussion in belly dancing.